| Literature DB >> 10601023 |
G Benoit1, L Altucci, M Flexor, S Ruchaud, J Lillehaug, W Raffelsberger, H Gronemeyer, M Lanotte.
Abstract
Although retinoic acid receptor alpha (RARalpha) agonists induce the maturation of t(15;17) acute promyelocytic leukemia (APL) cells, drug treatment also selects leukemic blasts expressing PML-RARalpha fusion proteins with mutated ligand-binding domains that no longer respond to all-trans retinoic acid (ATRA). Here we report a novel RARalpha-independent signaling pathway that induces maturation of both ATRA-sensitive and ATRA-resistant APL NB4 cells, and does not invoke the ligand-induced alteration of PML-RARalpha signaling, stability or compartmentalization. This response involves a cross-talk between RXR agonists and protein kinase A signaling. Our results indicate the existence of a separate RXR-dependent maturation pathway that can be activated in the absence of known ligands for RXR heterodimerization partners.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10601023 PMCID: PMC1171764 DOI: 10.1093/emboj/18.24.7011
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598